Subsidiary Aptn's Paid-in Capital Increase Amended
에이프로젠
007460
Signal Score
Historical Avg Return (5d)
+0.25%
Data Coverage
100%n=2486
Risk-adjusted indicator based on 2486 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • New Shares Issued: 3,500,000 Shares
- • Issue Price per Share: 1,000 KRW
- • Total Funding: 3,500,000,000 KRW
- • Dilution Rate: 17.80%
- • Original Shares Outstanding: 19,658,914 Shares
AI Analysis Summary
Aprogen's subsidiary, Aptn, announced an amendment to its third-party allotment paid-in capital increase. The payment date has been changed from July 7, 2026, to July 15, 2026, and the listing date from August 11, 2026, to August 19, 2026. The capital increase involves issuing 3,500,000 common shares at 1,000 KRW per share, raising a total of 3.5 billion KRW. The funds are designated for acquiring securities of other corporations, specifically GPCR Co., Ltd. The new shares represent a dilution of approximately 17.80% for existing shareholders. The original third-party allottee, Shin Dong-seung, has been replaced by SDS Holdings Co., Ltd., which is 100% owned by Shin Dong-seung and plans to fund the acquisition through borrowing. This dilution, while funding a new business, could negatively impact existing shareholder value.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.